Compare LOPE & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOPE | OPCH |
|---|---|---|
| Founded | 1949 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Nursing Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.7B |
| IPO Year | 2008 | 1996 |
| Metric | LOPE | OPCH |
|---|---|---|
| Price | $117.07 | $31.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 11 |
| Target Price | ★ $194.00 | $30.03 |
| AVG Volume (30 Days) | 245.5K | ★ 3.8M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | ★ 6.25 | 1.02 |
| Revenue | $511,257,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $5.60 | $1.91 |
| Revenue Next Year | $6.15 | $6.41 |
| P/E Ratio | ★ $24.11 | $31.03 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $134.27 | $18.01 |
| 52 Week High | $182.16 | $36.80 |
| Indicator | LOPE | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 17.92 | 76.72 |
| Support Level | N/A | $28.70 |
| Resistance Level | $156.72 | $31.90 |
| Average True Range (ATR) | 6.62 | 0.16 |
| MACD | -4.55 | -0.25 |
| Stochastic Oscillator | 1.00 | 62.86 |
Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges, both online and on the ground at its campus in Phoenix, Arizona, and at four off-site classroom andlaboratory sites. The Company generates all of its revenue through service agreements with its university partners.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.